Inhibition of Bcl-x(L) expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli

Oncogene

Volumn 18, Issue 31, 1999, Pages 4495-4504

  Taylor, Jennifer K ^a   Zhang, Qing Qing ^a   Monia, Brett P ^a   Marcusson, Eric G ^a   Dean, Nicholas M ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

Apoptosis; Bcl x(L); Epithelial cells; Keratinocytes

Indexed keywords

CISPLATIN; PROTEIN; PROTEIN BCL X; PROTEIN INHIBITOR; RNA; ANTISENSE OLIGONUCLEOTIDE; BCL2L1 PROTEIN, HUMAN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; EPIDERMIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN PROTECTION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; CELL CULTURE; CELL CYCLE; CELL STRAIN HL 60; CHEMISTRY; CYTOLOGY; DIPLOIDY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RADIATION EXPOSURE; SKIN;

APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; CELL CYCLE; CELLS, CULTURED; CISPLATIN; CLONING, MOLECULAR; DIPLOIDY; EPITHELIAL CELLS; HL-60 CELLS; HUMANS; KERATINOCYTES; LUNG NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN; TRANSFECTION; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0033526938     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202836     Document Type: Article

References (62)

1. Ackermann EJ, Taylor JK, Narayana R and Bennett CF. (1999). J. Biol. Chem., 274, 11245-11252.
2. Adams JM and Cory S. (1998). Science, 281, 1322-1326.
3. Allsopp TE, Wyatt S, Paterson HF and Davies AM. (1993). Cell, 73, 295-307.
4. Altmann K-H, Fabbro D, Dean NM, Geiger T, Monia BP, Muller M and Nicklin P. (1996). Biochem. Soc. Trans., 24, 630-637.
5. Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DEH, Witte ON and Green DR. (1998). Oncogene, 16, 1383-1390.
6. Bennett CF, Condon T, Grimm S, Chan H and Chiang M-Y. (1994). J. Immunol., 152, 3530-3540.
7. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Braden HP, Halperin AJ and Ponten J. (1991). Proc Natl. Acad. Sci. USA, 88, 10124-10128.
8. Carson DA and Lois A. (1995). Lancet, 346, 1009-1011.
9. Condon TP and Bennett CF. (1996). J. Biol. Chem., 271, 398-403.
10. Cotton J and Spandau DF. (1997). Radiat. Res., 147, 148-155.
11. Cox LS and Lane DP. (1995). BioEssays, 17, 501-508.
12. Dassonneville L and Bailly C. (1998). Bull. Cancer, 85, 254-261.
13. Dean NM and Griffey RH. (1997). Antisense Nucleic Drug Dev., 7, 229-233.
14. Dean NM, McKay R, Condon TP and Bennett CF. (1994). J. Biol. Chem., 269, 16416-16424.
15. Dean NM, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Zeil R, Geiger T, Muller M and Fabbro D. (1996). Cancer Res., 56, 3499-3507.
16. Deng G and Podack ER. (1993). Proc. Natl. Acad. Sci. USA, 90, 2189-2193.
17. Dhanwada KR, Dickens M, Neades R, Davis R and Pelling JC. (1995). Oncogene, 11, 1947-1953.
18. Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K and Kishimoto T. (1997). J. Clin. Invest., 99, 2898-2905.
19. Gniadecki R, Hansen M and Wulf HC. (1997). J. Invest. Dermatol., 109, 163-169.
20. Hall EJ, Astor M, Bedford J, Borek C, Curtis SB, Fry M, Geard C, Hei T, Mitchell J and Oleinick N, et al. (1998). Am J. Clin. Oncol., 11, 220-252.
21. Henseleit U, Rosenbach T and Kolde G. (1996). Arch. Dermatol. Res., 288, 676-683.
22. Ho SP, Britton DHO, Sonc BA, Behrens DL, Leffet LM, Hobbs FW, Miller JA and Trainor GL. (1996). Nucl. Acids Res., 24, 1901-1907.
23. Hockenbery DM, Zutter M, Hickey W. Hahm M and Korsmeyer SJ. (1991). Proc. Natl. Acad. USA, 88, 6961-6965.
24. Kamb A. (1994). Nature, 372, 730-731.
25. Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Miyagawa JI, Minami T, Kiyohara T, Zushi S, Kitamura S, Isozaki K and Matsuzawa Y. (1996). Int. J. Cancer, 68, 727-730.
26. Kirsh EJ, Baunoch DA and Stadler WM. (1998). J. Urol., 159, 1348-1353.
27. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR and Reed JC. (1996). Cancer Res., 56, 2422-2427.
28. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J and Reed JC. (1997). Am. J. Pathol., 150, 805-814.
29. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Ireie S, Fong L and Reed JC. (1994). Cancer Res., 54, 5501-5507.
30. Marvel J, Perkins GR, Lopez Rivas A and Collins MK. (1994). Oncogene, 9, 1117-1122.
31. McDonnell TJ and Korsmeyer SJ. (1991). Nature, 349, 254-256.
32. Miyashita T and Reed JC. (1992). Cancer Res., 52, 5407-5411.
33. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima W and Freier SM. (1992). J. Biol. Chem., 267, 19954-19962.
34. Motoyama N, Wang F, Roth K, Sawa H, Nakayama K, Hakayama K, Negishi I, Senju S, Zhang Q, Fugii S and Loh DY. (1995). Science, 267, 1506-1510.
35. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP and Korsmeyer SJ. (1990). J. Immunol., 144, 3602-3610.
36. Ohmori T, Podack ER, Nishio K, Takahashi M, Miyahara Y, Takeda Y, Kubota N, Funayama Y, Ogasawara H and Ohira T, et al. (1993). Biochem. Biophys. Res. Commun., 192, 30-36.
37. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB and Recant WM. (1997). Cancer J. Sci. Am., 3, 230-237.
38. Oltavi ZN and Korsmeyer SJ. (1994). Cell, 79, 189-192.
39. Parker SL, Tong T, Bolden S and Wingo PA. (1996). Ca Cancer J. Clin., 46, 5-27.
40. Pena JC, Fuchs E and Thompson CB. (1997). Cell Growth & Differ., 8, 619-629.
41. Pena JC, Rudin CM and Thompson CB. (1998). Cancer Res., 58, 2111-2116.
42. Pollman MJ, Hall JL, Mann MJ, Zhang L and Gibbons GH. (1998). Nature Med., 4, 222-227.
43. Ramaswamy NT, Ronai Z and Pelling JC. (1998). Oncogene, 16, 1501-1505.
44. Reed JC. (1997). J. Natl. Cancer Inst., 89, 988-990.
45. Rodeck U, Jost M, DuHadaway J, Kari C, Jensen PJ, Risse B and Ewert DL. (1997). Proc. Natl. Acad. Sci. USA, 94, 5067-5072.
46. Rodriguez-Villanueva J, Greenhalgh D, Wang X-J, Bundman D, Cho S, Delehedde M, Roop D and McDonnell TJ. (1998). Oncogene, 16, 853-863.
47. Saini KS and Walker NI. (1998). Mol. Cell. Biochem., 178, 9-25.
48. Sanchez Y and Elledge SJ. (1995). BioEssays, 17, 545-548.
49. Schmitt E, Cimoli G, Steyaert A and Bertrand R. (1998). Exp. Cell Res., 240, 107-121.
50. Schwandner R, Wiegmann K, Bernardo K, Kreder D and Kronke M. (1998). J. Biol. Chem., 273, 5916-5922.
51. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ. (1991). Cell, 67, 879-888.
52. Sermadiras S, Dumas M, Joly-Berville R, Bonte F, Meybeck A and Ratinaud MH. (1997). Bri. J. Dermatol., 137, 883-889.
53. Sierakowska H, Sambade MJ, Agrawal S and Kole R. (1996). Natl. Acad. Sci. USA, 93, 12840-12844.
54. Stoll SW, Benedict M, Mitra R, Hiniker A, Elder JT and Nunez G. (1998). Oncogene, 16, 1493-1499.
55. Strasser A, Harris AW and Cory S. (1991). Cell, 67, 889-899.
56. Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC and Li G. (1998). Am. J. Pathol., 153, 579-585.
57. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.
58. Veis DJ, Sorenson CM, Shutter JR and Korsmeyer SJ. (1993). Cell, 75, 229-240.
59. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ and Kohn KW. (1993). Cancer Res., 53, 1853-1861.
60. Webb A, Cunningham D, Cotter F, Clarke PA, di Stefano F, Ross P, Corbo M and Dziewanowska Z. (1997). Lancet, 349, 1137-1141.
61. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G and Nickoloff BJ. (1995). Am J. Pathol., 146, 1079-1088.
62. Yang E and Korsmeyer SJ. (1996). Blood, 88, 386-401.